Pulmonary fibrosis and COVID-19: the potential role for antifibrotic therapy
Peter M. George, Athol U. Wells, Gísli Jenkins
Topics & Concepts
MedicinePulmonary fibrosisPneumoniaInternal medicineIdiopathic pulmonary fibrosisPandemicIntensive care medicineFibrosisARDSDiffuse alveolar damageDiseaseCoronavirusCoronavirus disease 2019 (COVID-19)ImmunologyLungAcute respiratory distressInfectious disease (medical specialty)Interstitial Lung Diseases and Idiopathic Pulmonary FibrosisSarcoidosis and Beryllium Toxicity ResearchEosinophilic Disorders and Syndromes